Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?
The TWEAK/Fn 14 pathway is now well known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00489/full |